CA2432111A1 - Jfy1 protein induces rapid apoptosis - Google Patents

Jfy1 protein induces rapid apoptosis Download PDF

Info

Publication number
CA2432111A1
CA2432111A1 CA002432111A CA2432111A CA2432111A1 CA 2432111 A1 CA2432111 A1 CA 2432111A1 CA 002432111 A CA002432111 A CA 002432111A CA 2432111 A CA2432111 A CA 2432111A CA 2432111 A1 CA2432111 A1 CA 2432111A1
Authority
CA
Canada
Prior art keywords
jfy1
seq
expression
isolated
pro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002432111A
Other languages
English (en)
French (fr)
Inventor
Jian Yu
Kenneth W. Kinzler
Bert Vogelstein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johns Hopkins University
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2432111A1 publication Critical patent/CA2432111A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/20—Screening for compounds of potential therapeutic value cell-free systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CA002432111A 2000-12-19 2001-12-12 Jfy1 protein induces rapid apoptosis Abandoned CA2432111A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25632800P 2000-12-19 2000-12-19
US60/256,328 2000-12-19
PCT/US2001/047455 WO2002064790A2 (en) 2000-12-19 2001-12-12 Jfy1 protein induces rapid apoptosis

Publications (1)

Publication Number Publication Date
CA2432111A1 true CA2432111A1 (en) 2002-08-22

Family

ID=22971833

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002432111A Abandoned CA2432111A1 (en) 2000-12-19 2001-12-12 Jfy1 protein induces rapid apoptosis

Country Status (4)

Country Link
EP (1) EP1343884A2 (de)
JP (1) JP2004530422A (de)
CA (1) CA2432111A1 (de)
WO (1) WO2002064790A2 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7192713B1 (en) 1999-05-18 2007-03-20 President And Fellows Of Harvard College Stabilized compounds having secondary structure motifs
US7202024B2 (en) * 2001-09-17 2007-04-10 Immunogen Inc. bbc3 Gene promoter and methods for identifying modulators of apoptosis and bbc3 gene expression using a bbc3 gene promoter
ES2586387T3 (es) 2003-11-05 2016-10-14 Dana-Farber Cancer Institute, Inc. Péptidos alfa helicoidales adecuados para activar o inhibir la muerte celular
DK2118123T3 (en) 2007-01-31 2016-01-25 Dana Farber Cancer Inst Inc Stabilized p53 peptides and uses thereof
US8592377B2 (en) 2007-03-28 2013-11-26 President And Fellows Of Harvard College Stitched polypeptides
DE112009000300T5 (de) 2008-02-08 2011-01-20 Aileron Therapeutics, Inc., Cambridge Therapeutische Peptidomimetische Makrocyclen
EP2356139A4 (de) 2008-07-23 2013-01-09 Harvard College Ligieren zusammengehefteter polypeptide
CN102203126A (zh) 2008-09-22 2011-09-28 爱勒让治疗公司 用于制备纯化的多肽组合物的方法
US9175047B2 (en) 2009-01-14 2015-11-03 Aileron Therapeutics, Inc. Peptidomimetic macrocycles
AU2010273220B2 (en) 2009-07-13 2015-10-15 President And Fellows Of Harvard College Bifunctional stapled polypeptides and uses thereof
CN102712675A (zh) 2009-09-22 2012-10-03 爱勒让治疗公司 拟肽大环化合物
ES2711526T3 (es) 2010-08-13 2019-05-06 Aileron Therapeutics Inc Macrociclos peptidomiméticos
WO2012040459A2 (en) 2010-09-22 2012-03-29 President And Fellows Of Harvard College Beta-catenin targeting peptides and uses thereof
US9487562B2 (en) 2011-06-17 2016-11-08 President And Fellows Of Harvard College Stabilized polypeptides as regulators of RAB GTPase function
TW201806968A (zh) 2011-10-18 2018-03-01 艾利倫治療公司 擬肽巨環化合物
EP2819688A4 (de) 2012-02-15 2015-10-28 Aileron Therapeutics Inc Triazol- und thioethervernetzte peptidomimetische makrozyklen
BR112014020103A2 (pt) 2012-02-15 2018-10-09 Aileron Therapeutics, Inc. macrociclos peptidomiméticos
WO2014052647A2 (en) 2012-09-26 2014-04-03 President And Fellows Of Harvard College Proline-locked stapled peptides and uses thereof
WO2014071241A1 (en) 2012-11-01 2014-05-08 Aileron Therapeutics, Inc. Disubstituted amino acids and methods of preparation and use thereof
EP3391898A3 (de) 2013-03-13 2019-02-13 President and Fellows of Harvard College Gestapelte und geheftete polypeptide und verwendungen davon
JP2016523241A (ja) 2013-06-14 2016-08-08 プレジデント アンド フェローズ オブ ハーバード カレッジ 安定化されたポリペプチドインスリン受容体調節剤
CA2949535C (en) 2014-05-21 2023-09-12 President And Fellows Of Harvard College Ras inhibitory peptides and uses thereof
EP3197478A4 (de) 2014-09-24 2018-05-30 Aileron Therapeutics, Inc. Peptidomimetische makrozyklen und verwendungen davon
AU2015320545C1 (en) 2014-09-24 2020-05-14 Aileron Therapeutics, Inc. Peptidomimetic macrocycles and formulations thereof
WO2016154058A1 (en) 2015-03-20 2016-09-29 Aileron Therapeutics, Inc. Peptidomimetic macrocycles and uses thereof
JP6622007B2 (ja) * 2015-05-29 2019-12-18 オリンパス株式会社 細胞評価方法
US10059741B2 (en) 2015-07-01 2018-08-28 Aileron Therapeutics, Inc. Peptidomimetic macrocycles
WO2017044633A1 (en) 2015-09-10 2017-03-16 Aileron Therapeutics, Inc. Peptidomimetic macrocycles as modulators of mcl-1

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1129102A1 (de) * 1998-11-02 2001-09-05 Clontech Laboratories Inc. Gene und protein zur regulierung des zelltodes

Also Published As

Publication number Publication date
EP1343884A2 (de) 2003-09-17
WO2002064790A3 (en) 2003-05-30
JP2004530422A (ja) 2004-10-07
WO2002064790A2 (en) 2002-08-22

Similar Documents

Publication Publication Date Title
CA2432111A1 (en) Jfy1 protein induces rapid apoptosis
Yu et al. PUMA induces the rapid apoptosis of colorectal cancer cells
US5863795A (en) Nucleic acids that encode peptides which modulate apoptosis
JP2001502894A (ja) ドメイン死アゴニストと相互作用するｂｈ３
US5695963A (en) Endothelial PAS domain protein
US20080220455A1 (en) p53-DEPENDENT APOPTOSIS-INDUCING PROTEIN AND METHOD OF SCREENING FOR APOPTOSIS REGULATOR
JP2010233569A (ja) アポトーシスを調節する方法および組成物
US20040146971A1 (en) Novel p53 inducible protein
KR20010022741A (ko) 신규 노화-인자 유전자, ｐ23의 단리
US20040228866A1 (en) Suppressor genes
WO1998040397A1 (en) Bax inhibitor proteins
JP2006524508A (ja) 骨関連の活性を調節する新規な方法
AU2004223739B2 (en) Cyclic AMP response element activator proteins and uses related thereto
US7053194B2 (en) Compositions and methods for p53-mediated repression of gene expression
CN115607675B (zh) Nav1.9互作蛋白PRMT7及其下调剂在制备镇痛药物中的用途
US20050220781A1 (en) IFIX, a novel HIN-200 protein, for cancer therapy
US20040241797A1 (en) Use of alphacp1, alphacp2, and hur for modulating gene expression and inducing angiogenesis
US20040077832A1 (en) Jfy1protein induces rapid apoptosis
AU2002253804A1 (en) JFY1 protein induces rapid apoptosis
JP2000511781A (ja) アポトーシスを調節する方法および試薬
WO2000026634A2 (en) Compositions and methods for screening agents that inhibit mapk mediated anti-apoptotic signals
JP2002541760A (ja) ｃ−ｍｙｃはβ−カテニンおよびＴＣＦ−４によって活性化される
JP2005526485A (ja) ｂｂｃ３遺伝子プロモーターならびにｂｂｃ３遺伝子プロモーターを用いてアポトーシスおよびｂｂｃ３遺伝子発現のモジュレーターを同定する方法
US20030073236A1 (en) p193 proteins and nucleic acids, and uses thereof
JP4280878B2 (ja) Ｍａｓｌ１遺伝子

Legal Events

Date Code Title Description
FZDE Dead